Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Asymchem Labs Ups its China Investment – Again

publication date: Dec 28, 2007

Asymchem Laboratories is very much a company on the move. Headquartered in the Research Triangle Park of North Carolina, Asymchem makes chemical intermediates and APIs in six locations in China. So far, it has invested 1.7 billion RMB ($227 million) in its China facilities. Asymchem announced that it will put another 300 million RMB ($40 million) to work building a 100,000 square meter facility in the Dagang Development Zone (DEDA) of Tianjin, north China. This is in addition to the 480 million RMB ($64 million) it will spend on the Asymchem Life Science Co. facility, located in the Tianjin Economic-Technological Development Area (TEDA). More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital